Harald E. Vonkeman

6.1k total citations
143 papers, 3.1k citations indexed

About

Harald E. Vonkeman is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, Harald E. Vonkeman has authored 143 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Rheumatology, 25 papers in Pharmacology and 20 papers in Surgery. Recurrent topics in Harald E. Vonkeman's work include Rheumatoid Arthritis Research and Therapies (69 papers), Systemic Lupus Erythematosus Research (21 papers) and Spondyloarthritis Studies and Treatments (19 papers). Harald E. Vonkeman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (69 papers), Systemic Lupus Erythematosus Research (21 papers) and Spondyloarthritis Studies and Treatments (19 papers). Harald E. Vonkeman collaborates with scholars based in Netherlands, United States and Canada. Harald E. Vonkeman's co-authors include Mart A F J van de Laar, D. A. van Dorp, Peter M. ten Klooster, Rolf Beerthuis, I. Meek, D.H. Nugteren, Mart AFJ van de Laar, Erik Taal, Martijn A. H. Oude Voshaar and Piet L. C. M. van Riel and has published in prestigious journals such as Nature, PLoS ONE and The Journal of Comparative Neurology.

In The Last Decade

Harald E. Vonkeman

132 papers receiving 2.9k citations

Peers

Countries citing papers authored by Harald E. Vonkeman

Since Specialization

Citations

This map shows the geographic impact of Harald E. Vonkeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald E. Vonkeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald E. Vonkeman more than expected).

Fields of papers citing papers by Harald E. Vonkeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald E. Vonkeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald E. Vonkeman. The network helps show where Harald E. Vonkeman may publish in the future.

Co-authorship network of co-authors of Harald E. Vonkeman

This figure shows the co-authorship network connecting the top 25 collaborators of Harald E. Vonkeman. A scholar is included among the top collaborators of Harald E. Vonkeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald E. Vonkeman. Harald E. Vonkeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of a web-based self-monitoring application (MyRA) to empower people with rheumatoid arthritis in daily life 2025 ·Lara D. Veeken ·Laura Hochstenbach, (unknown), (unknown), (unknown), Anouk M. Knops, Marieke D. Spreeuwenberg, Harald E. Vonkeman, Astrid van Tubergen	1
2	Exploring difficult-to-manage axial spondyloarthritis: results from a Dutch clinical practice registry 2025 ·Lara D. Veeken ·(unknown), Casper Webers, Harald E. Vonkeman, Astrid van Tubergen	1
3	What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment 2024 ·RMD Open ·Rieke Alten, Juan Carlos Nieto‐González, Peggy Jacques, Carlomaurizio Montecucco, Robert J. Moots, Helga Radner, Harald E. Vonkeman, Sebastian Heidenreich, Chiara Whichello, Nicolas Krucien, Katrien Van Beneden	0
4	Experiences with patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis: a mixed methods study 2024 ·Lara D. Veeken ·(unknown), (unknown), Annelies Boonen, Harald E. Vonkeman, Casper Webers, Astrid van Tubergen	0
5	One-year trajectories of physical and mental health-related quality of life, fatigue and dyspnoea in COVID-19 survivors 2024 ·Quality of Life Research ·(unknown), (unknown), Peter M. ten Klooster, Carine J.M. Doggen, Job van der Palen, Christina Bode, Harald E. Vonkeman	1
6	The effect of corticosteroids, antibiotics, and anticoagulants on the development of post-COVID-19 syndrome in COVID-19 hospitalized patients 6 months after discharge: a retrospective follow up study 2023 ·Clinical and Experimental Medicine ·(unknown), Naomi T. Jessurun, (unknown), Christina Bode, Harald E. Vonkeman	8
7	Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry 2023 ·The Journal of Rheumatology ·Casper Webers, Annelies Boonen, Harald E. Vonkeman, Astrid van Tubergen	4
8	Further evaluation of inflammatory and non-inflammatory aspects of pain in rheumatoid arthritis patients 2023 ·Rheumatology Advances in Practice ·(unknown), Peter M. ten Klooster, Harald E. Vonkeman, (unknown), Jan R. Buitenweg	6
9	“It Really Is an Elusive Illness”—Post-COVID-19 Illness Perceptions and Recovery Strategies: A Thematic Analysis 2022 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), Carine J.M. Doggen, Job van der Palen, Harald E. Vonkeman, Christina Bode	11
10	Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals 2022 ·Lara D. Veeken ·(unknown), Polina Putrik, (unknown), Jany Rademakers, Harald E. Vonkeman, Marc R. Kok, (unknown), Sofía Ramiro, Maarten de Wit, Rachelle Buchbinder, Roy Batterham, Richard H. Osborne, Annelies Boonen	6
11	Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands 2021 ·Rheumatology International ·Wouter H Bos, Astrid van Tubergen, Harald E. Vonkeman	49
12	Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals 2021 ·The Journal of Rheumatology ·(unknown), Naomi T. Jessurun, Sander W. Tas, Bart J. F. van den Bemt, Michael T. Nurmohamed, Martijn B. A. van Doorn, Phyllis I. Spuls, Astrid van Tubergen, Peter M. ten Klooster, Eugène van Puijenbroek, Frank Hoentjen, Harald E. Vonkeman	0
13	Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients 2020 ·Expert Opinion on Drug Safety ·(unknown), Naomi T. Jessurun, Florence van Hunsel, Eugène van Puijenbroek, Astrid van Tubergen, Peter M. ten Klooster, Harald E. Vonkeman	11
14	SAT0558 IDENTIFYING HEATH LITERACY PROFILES OF RA AND SPA PATIENTS USING THE HEALTH LITERACY QUESTIONNAIRE 2019 ·Annals of the Rheumatic Diseases ·(unknown), Polina Putrik, Jany Rademakers, Mart van de Laar, Harald E. Vonkeman, Marc R. Kok, (unknown), Sofía Ramiro, Maarten de Wit, Richard H. Osborne, Roy Batterham, Rachelle Buchbinder, Annelies Boonen	0
15	A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties 2019 ·Health and Quality of Life Outcomes ·(unknown), Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim Jansen, Harald E. Vonkeman, Mart A F J van de Laar	5
16	Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare 2019 ·Clinical Rheumatology ·(unknown), Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Harald E. Vonkeman, Mart A F J van de Laar	10
17	The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands. 2018 ·PubMed ·(unknown), Sofía Ramiro, Polina Putrik, Yvonne van Eijk‐Hustings, Anthony D. Woolf, Josef S Smolen, Michaela Stoffer, T. Uhlig, Rikke Helene Moe, (unknown), (unknown), Annette H M van der Helm–van Mil, Mart van de Laar, Harald E. Vonkeman, Maarten de Wit, Annelies Boonen	1
18	A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands 2018 ·Clinical Rheumatology ·(unknown), Martijn A. H. Oude Voshaar, Harald E. Vonkeman, (unknown), Mart A F J van de Laar	12
19	Relative Performance of Commonly Used Physical Function Questionnaires in Rheumatoid Arthritis and a Patient‐Reported Outcomes Measurement Information System Computerized Adaptive Test 2014 ·Arthritis & Rheumatology ·Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Cees A. W. Glas, Harald E. Vonkeman, Eswar Krishnan, Mart A F J van de Laar	17
20	Experiences of gout-related disability from the patients’ perspective: a mixed methods study 2013 ·Clinical Rheumatology ·Peter M. ten Klooster, Harald E. Vonkeman, Martijn A. H. Oude Voshaar, Christina Bode, Mart A F J van de Laar	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact